If you’re living with obesity, medications like semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) may be an important part of your treatment plan. These glucagon-like peptide-1 (GLP-1) receptor agonists — a type of medicine to help regulate appetite and blood sugar — have shown promising results in helping people manage their weight and improve their health. However, getting insurance coverage for these medications can sometimes be a challenge.
This article will walk you through the process and share five practical tips to improve your chances of getting your medication covered by insurance — even if you run into some bumps along the way.
Insurance companies have specific rules about which medications they’ll cover. Understanding these rules can help improve your chances of getting your GLP-1 medication approved. Although the details may vary by insurer and plan, here are some common requirements.
Insurance may cover GLP-1 medications for people diagnosed with obesity, which is usually defined as a body mass index (BMI) of 30 or higher. Some plans may also cover these drugs for people with a BMI of 27 or higher if they also have other weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol. Note that the BMI is a measure based on height and weight and is unrelated to any specific body type or size.
Coverage for GLP-1 medications can vary a lot between insurance plans. For example, the U.S. Food and Drug Administration (FDA) approved semaglutide sold under the brand name Ozempic mainly for treating type 2 diabetes, so it’s more likely to be covered when prescribed for that reason. Wegovy, another brand that contains the same active ingredient, is specifically approved for managing obesity, but not all insurance plans cover it. So even if you qualify medically, your plan might still say no to Wegovy.
Most insurance companies require prior authorization for GLP-1 drugs. This means your doctor has to send in paperwork showing that the medication is necessary for you. Without this step, the insurance company may automatically deny coverage.
One of the most important steps to getting GLP-1 medication covered involves asking your doctor for a Letter of Medical Necessity. This letter explains why the medication is needed for your health and how it fits with current clinical guidelines for treating obesity. The letter should include:
Generally, the more complete and specific this letter is, the better your chances of approval for insurance coverage.
Most insurance companies want to see proof that you've tried to lose weight before they’ll approve coverage for GLP-1 drugs. Keeping a record of your past efforts can help support your case. These attempts might include:
This documentation shows that you’ve made consistent efforts to manage your weight, but these approaches didn’t work well enough, so GLP-1 medications are the next medically appropriate step.
Not all insurance plans cover GLP-1 drugs, so it’s important to find out what your plan does — before starting treatment. Here are some easy ways to check:
If the medication is listed but has restrictions, you may need to complete extra steps — or file an appeal — to get it approved.
If your insurance company denies coverage for GLP-1 medications, you have the right to appeal the decision. Here’s how to get started:
If your insurance doesn’t cover GLP-1 drugs, you still have options to help lower the cost of these medications.
Drug companies such as Novo Nordisk, which makes semaglutide medications (Ozempic and Wegovy), offer savings cards to help reduce out-of-pocket costs for people who qualify. Visit the manufacturers’ websites or speak with your doctor to learn how to apply for these programs.
Nonprofit organizations such as the PAN Foundation and NeedyMeds may offer grants, discounts, or other resources for people who need assistance paying for medications. Some for-profit companies, like GoodRx, can also help you compare prices and find discounts on prescription medications.
Medicaid coverage for GLP-1 drugs varies depending on the state. In some (but not all) states, Wegovy may be covered for managing obesity. Ozempic is more often covered when prescribed for type 2 diabetes, but less commonly for weight loss. To find what’s covered where you live, contact your local Medicaid office.
If your insurance doesn’t cover GLP-1 medications, don’t give up — there are still other paths to consider.
Semaglutide sold as Wegovy is currently the most commonly prescribed GLP-1 medication for managing obesity. But if it’s not covered by your plan, ask your doctor about other options. Liraglutide and tirzepatide are also FDA-approved for weight loss and may be covered by your insurance.
Consider speaking with a patient advocate or using tools like the Health Insurance Marketplace. These resources may help you compare plans that provide better access to medications for weight management.
Remember, medication is just one part of a treatment plan for managing obesity. Eating nutritious food, staying active, and making behavior changes provide the foundation of long-term health. GLP-1 drugs can support these efforts, but they’re not a replacement for healthy habits.
On MyObesityTeam, the social network and online support group for people with obesity and their loved ones, more than 56,000 members come together to share experiences, seek advice, and offer support.
Have you been prescribed a GLP-1 medication for weight management? What steps have you taken to get insurance coverage for your medication? Share your thoughts in a comment below, or start a conversation by posting on your Activities page.
Become a member to get even more